The Anti-Mesothelin Monoclonal Antibody Amatuximab Enhances the Anti-Tumor Effect of Gemcitabine Against Mesothelin-High Expressing Pancreatic Cancer Cells in a Peritoneal Metastasis Mouse Model

Oncotarget - United States
doi 10.18632/oncotarget.26117

Related search